AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided …
4-traders (press release) Aerocrine AB (STO:AERO-B) – A new randomised clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment. The study has been published on … |
View full post on asthma – Google News